• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

当代全乳放疗指南：另一种视角。

Contemporary Guidelines in Whole-Breast Irradiation: An Alternative Perspective.

机构信息

Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.

Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Beverly Hills, California.

出版信息

Int J Radiat Oncol Biol Phys. 2019 Jul 1;104(3):567-573. doi: 10.1016/j.ijrobp.2018.10.014. Epub 2018 Oct 23.

DOI:10.1016/j.ijrobp.2018.10.014
PMID:30366007
Abstract

The American Society for Radiation Oncology produced an evidence-based guideline on whole-breast radiation therapy for patients with early-stage invasive breast cancer and ductal carcinoma in situ. This commentary points out areas where we believe the data are too limited to make definitive recommendations and where alternative approaches are supported by evidence.

摘要

美国放射肿瘤学会针对早期浸润性乳腺癌和导管原位癌患者的全乳放射治疗制定了一项基于证据的指南。本评论指出了我们认为数据过于有限，无法做出明确建议的领域，以及有证据支持替代方法的领域。

相似文献

1
Contemporary Guidelines in Whole-Breast Irradiation: An Alternative Perspective.当代全乳放疗指南：另一种视角。
Int J Radiat Oncol Biol Phys. 2019 Jul 1;104(3):567-573. doi: 10.1016/j.ijrobp.2018.10.014. Epub 2018 Oct 23.
2
Hypofractionated radiation treatment in the management of breast cancer.乳腺癌的分段式放射治疗。
Expert Rev Anticancer Ther. 2018 Aug;18(8):793-803. doi: 10.1080/14737140.2018.1489245. Epub 2018 Jun 26.
3
Breast irradiation in women with early stage invasive breast cancer following breast conservation surgery. Provincial Breast Disease Site Group.保乳手术后早期浸润性乳腺癌女性的乳房放疗。省级乳腺疾病站点组。
Cancer Prev Control. 1997 Aug;1(3):228-40.
4
Hypofractionated whole-breast radiotherapy for women with early breast cancer: myths and realities.早期乳腺癌女性的大分割全乳放疗：误区与真相
Int J Radiat Oncol Biol Phys. 2011 Jan 1;79(1):1-9. doi: 10.1016/j.ijrobp.2010.08.035. Epub 2010 Oct 13.
5
Radiation therapy for young women with early breast cancer: Current state of the art.早期乳腺癌年轻女性的放射治疗：现状。
Crit Rev Oncol Hematol. 2019 May;137:143-153. doi: 10.1016/j.critrevonc.2019.02.014. Epub 2019 Mar 2.
6
Are We Choosing Wisely in Radiation Oncology Practice-Findings From an Australian Population-Based Study.在放射肿瘤学实践中，我们是否明智选择？来自澳大利亚基于人群的研究结果。
Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):1012-1016. doi: 10.1016/j.ijrobp.2019.03.048. Epub 2019 Apr 12.
7
Temporal impact of the publication of guidelines and randomised evidence on the adoption of hypofractionated whole breast radiotherapy for early-stage breast cancer.指南和随机证据的发表对早期乳腺癌采用大分割全乳放疗的时间影响。
J Med Imaging Radiat Oncol. 2019 Aug;63(4):530-537. doi: 10.1111/1754-9485.12897. Epub 2019 May 14.
8
Cost-effectiveness Analysis Comparing Conventional, Hypofractionated, and Intraoperative Radiotherapy for Early-Stage Breast Cancer.早期乳腺癌常规放疗、低分割放疗与术中放疗的成本效果分析。
J Natl Cancer Inst. 2017 Nov 1;109(11). doi: 10.1093/jnci/djx068.
9
NCCN Guidelines Update: Evolving Radiation Therapy Recommendations for Breast Cancer.NCCN 指南更新：乳腺癌放射治疗推荐的演变。
J Natl Compr Canc Netw. 2017 May;15(5S):682-684. doi: 10.6004/jnccn.2017.0072.
10
Lag Time Between Evidence and Guidelines: Can Clinical Pathways Bridge the Gap?证据与指南之间的滞后时间：临床路径能否弥合差距？
J Oncol Pract. 2019 Mar;15(3):e195-e201. doi: 10.1200/JOP.18.00430. Epub 2018 Dec 7.

引用本文的文献

1
Screening of Specific and Common Pathways in Breast Cancer Cell Lines MCF-7 and MDA-MB-231 Treated with Chlorophyllides Composites.用叶绿素复合物处理 MCF-7 和 MDA-MB-231 乳腺癌细胞系中的特定和常见通路的筛选。
Molecules. 2022 Jun 20;27(12):3950. doi: 10.3390/molecules27123950.
2
Disease Control After Hypofractionation Versus Conventional Fractionation for Triple Negative Breast Cancer: Comparative Effectiveness in a Large Observational Cohort.三阴性乳腺癌Hypofractionation 与常规分割放疗后疾病控制：大型观察队列中的比较有效性。
Int J Radiat Oncol Biol Phys. 2022 Mar 15;112(4):853-860. doi: 10.1016/j.ijrobp.2021.10.012. Epub 2021 Oct 28.
3
Moderate hypofractionation remains the standard of care for whole-breast radiotherapy in breast cancer: Considerations regarding FAST and FAST-Forward.
中度分割仍然是乳腺癌全乳放射治疗的标准治疗方法：关于 FAST 和 FAST-Forward 的考虑。
Strahlenther Onkol. 2021 Apr;197(4):269-280. doi: 10.1007/s00066-020-01744-3. Epub 2021 Jan 28.
4
Physician trajectories of abandoning long-course breast radiotherapy and their cost impact.放弃长程乳腺癌放射治疗的医生路径及其成本影响。
Health Serv Res. 2021 Jun;56(3):497-506. doi: 10.1111/1475-6773.13572. Epub 2020 Oct 18.
5
Acute toxicity of normofractionated intensity modulated radiotherapy with simultaneous integrated boost compared to three-dimensional conformal radiotherapy with sequential boost in the adjuvant treatment of breast cancer.常规分割调强放疗同步推量与三维适形放疗序贯推量在乳腺癌辅助治疗中的急性毒性比较。
Radiat Oncol. 2020 Oct 13;15(1):235. doi: 10.1186/s13014-020-01652-x.